After declaring Chapter 11 bankruptcy in May of 2025, once-giant WeightWatchers (rebranded to WW beginning in 2018) admitted ...

Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

H ealth officials in the UK are launching an investigation into weight loss drugs after hundreds of consumers reported ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

More than 38 million people in the U.S. are living with diabetes.

The Dalai Lama said on Wednesday the institution of the Dalai Lama will continue and the Gaden Phodrang trust has sole ...

Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

The country’s Medicines and Healthcare products Regulatory Agency’s Yellow Card scheme, the UK’s official system for ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...